Anaferon children's tab. # 20

Dosage form

topical solution

Manufacturer

Infamed, Russia

Structure

Solution for topical application 0.01% colorless, transparent, foaming on shaking.

1 lbenzyldimethyl-myristoylamino-propylammonium chloride monohydrate 100 mg.

Excipients: purified water - up to 1 liter.

pharmachologic effect

Miramistin has a wide spectrum of antimicrobial activity, including hospital strains that are resistant to antibiotics.

The drug has a pronounced bactericidal effect against gram-positive (Staphylococcus spp., Streptococcus spp., Streptococcus pneumoniae, etc.), gram-negative (Pseudomonas aeruginosa, Escherichia coli, Klebsiella spp., Etc.), aerobic and anaerobic bacteria, determined microbial associations, including hospital strains with multidrug resistance to antibiotics.

It has an antifungal effect on ascomycetes of the genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata, etc.) and yeast-like fungi (Candida albicans, Candida tropicalis, Candida krusei, Pityrosporum orbiculare (Malassezia), furfurfurf dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violacent, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis and other pathogenic fungi, etc.), and other pathogenic fungi , including fungal microflora with resistance to chemotherapy drugs.

It has an antiviral effect, is active against complex viruses (herpes viruses, human immunodeficiency virus, etc.).

Miramistin acts on the causative agents of sexually transmitted diseases (Chlamydia spp., Treponema spp., Trichomonas vaginalis, Neisseria gonorrhoeae, etc.).

Effectively prevents infection of wounds and burns.

It activates the regeneration processes.

Stimulates protective reactions at the site of application, by activating the absorption and digestion functions of phagocytes, potentiates the activity of the monocytic-macrophage system.

It has a pronounced hyperosmolar activity, as a result of which it relieves wound and perifocal inflammation, absorbs purulent exudate, contributing to the formation of a dry scab.

Does not damage granulation and viable skin cells, does not inhibit marginal epithelization.

Does not possess local irritating effect and allergenic properties.

Pharmacokinetics

When applied topically, miramistin does not have the ability to be absorbed through the skin and mucous membranes.

Indications

For use in surgery, traumatology:

prevention of suppuration and treatment of purulent wounds

- treatment of purulent-inflammatory processes of the musculoskeletal system.

For use in obstetrics, gynecology:

prevention and treatment of suppuration of postpartum injuries, perineal and vaginal wounds, postpartum infections

prevention and treatment of inflammatory diseases (vulvovaginitis, endometritis).

For use in combustiology:

treatment of superficial and deep burns of II and III A degree

preparation of burn wounds for dermatoplasty.

For use in dermatology, venereology:

treatment and prevention of pyoderma and dermatomycosis, candidiasis of the skin and mucous membranes,

individual prevention of sexually transmitted diseases (including syphilis, gonorrhea, chlamydia, trichomoniasis, genital herpes, genital candidiasis).

For use in urology:

complex treatment of acute and chronic urethritis and urethroprostatitis of a specific (, trichomoniasis, gonorrhea) and non-specific nature.

For use in dentistry:

treatment and prevention of infectious and inflammatory diseases of the oral cavity: stomatitis, gingivitis, periodontitis, periodontitis

hygienic processing of removable dentures.

For use in otorhinolaryngology:

complex treatment of acute and chronic sinusitis, tonsillitis, laryngitis

complex treatment of acute pharyngitis and / or exacerbation of chronic tonsillitis in children aged 3 to 14 years.

Contraindications

Individual intolerance to the drug.

Side effects

In some cases, a slight burning sensation may occur at the injection site, which disappears on its own after 15–20 s and does not require discontinuation of the drug.

Allergic reactions.

Interaction

With simultaneous use with antibiotics, an increase in their antibacterial and antifungal properties has been noted.

How to take, course of administration and dosage

Locally.

The drug is ready for use.

Instructions for using the spray pack:

1. Remove the cap from the bottle.

2. Remove the supplied spray nozzle from the protective packaging.

3. Attach the spray nozzle to the bottle.

4. Activate the spray nozzle by pressing again.

Surgery, traumatology, combustiology. For prophylactic and therapeutic purposes, the surface of wounds and burns is irrigated, wounds and fistulous passages are loosely tamponed, gauze tampons moistened with the drug are fixed. The treatment procedure is repeated 2-3 times a day for 3-5 days. A highly effective method of active drainage of wounds and cavities with a daily consumption of up to 1 liter of the drug.

Obstetrics, gynecology. In order to prevent postpartum infection, it is used in the form of vaginal irrigation before childbirth (5-7 days), during childbirth after each vaginal examination and in the postpartum period, 50 ml of the drug in the form of a tampon with an exposure of 2 hours for 5 days. When women are delivered by cesarean section, immediately before the operation, the vagina is treated, during the operation - the uterine cavity and an incision on it, and in the postoperative period, tampons moistened with the drug are inserted into the vagina with an exposure of 2 hours for 7 days. Treatment of inflammatory diseases is carried out in a course of 2 weeks by intravaginal administration of tampons with the drug, as well as by the method of drug electrophoresis.

Venereology.

For the prevention of sexually transmitted diseases, the drug is effective if it is used no later than 2 hours after intercourse.

Introduce the contents of the vial with the urological applicator into the urethra for 2-3 minutes: for men - 2-3 ml, for women - 1-2 ml, and into the vagina - 5-10 ml.

Treat the skin of the inner surfaces of the thighs, pubis, genitals.

After the procedure, it is recommended not to urinate for 2 hours.

Urology.

In the complex treatment of urethritis and urethroprostatitis, 2-3 ml of the drug is injected into the urethra 1-2 times a day, the course is 10 days.

Otorhinolaryngology.

With purulent sinusitis - during puncture, the maxillary sinus is washed with a sufficient amount of the drug.

Tonsillitis, pharyngitis and laryngitis are treated by gargling and / or irrigation using a spray nozzle, 3-4 times pressing 3-4 times a day.

The amount of the preparation for 1 rinse is 10-15 ml.

In children.

In case of acute pharyngitis and / or exacerbation of chronic tonsillitis, irrigation of the pharynx is carried out using a spray nozzle.

Children aged 3–6 years - 3-5 ml for one irrigation (single press on the head of the spray nozzle) 3-4 times a day

7-14 years old - 5-7 ml for one irrigation (double pressing) 3-4 times a day

over 14 years old - 10-15 ml per one irrigation (3-4 times pressing) 3-4 times a day.

The duration of therapy is from 4 to 10 days, depending on the timing of the onset of remission.

Dentistry.

For stomatitis, gingivitis, periodontitis, it is recommended to rinse the mouth with 10-15 ml of the drug 3-4 times a day.

Release form

topical solution

Storage conditions

At a temperature not exceeding 25 ° C.

Shelf life

3 years

Brand name

MIRAMISTIN

Active substance

Benzyldimethyl 3- (myristoylamino) propylammonium chloride monohydrate

Terms of dispensing from pharmacies

Without recipe

Name ENG

MIRAMISTIN

Clinical and pharmacological group

Topical antiseptic

ATX code

Quaternary ammonium compounds

Dosage

0.01% x 150ml

Structure

Solution for topical application 0.01% colorless, transparent, foaming on shaking. 1 lbenzyldimethyl-myristoylamino-propylammonium chloride monohydrate 100 mg.

Excipients: purified water - up to 1 liter.

Indications

Surgery, traumatology: prevention of suppuration and treatment of purulent wounds.

Treatment of purulent-inflammatory processes of the musculoskeletal system.

Obstetrics, gynecology: prevention and treatment of suppuration of postpartum injuries, perineal and vaginal wounds, postpartum infections, inflammatory diseases (vulvovaginitis, endometritis).

Combustiology: treatment of superficial and deep burns of II and IIIA degrees, preparation of burn wounds for dermatoplasty.

Dermatology, venereology: treatment and prevention of pyoderma and dermatomycosis, candidiasis of the skin and mucous membranes, mycoses of the feet.

Individual prevention of sexually transmitted diseases (including syphilis, gonorrhea, chlamydia, trichomoniasis, genital herpes, genital candidiasis).

Urology: complex treatment of acute and chronic urethritis and urethroprostatitis of a specific (chlamydia, trichomoniasis, gonorrhea) and non-specific nature.

Dentistry: treatment and prevention of infectious and inflammatory diseases of the oral cavity: stomatitis, gingivitis, periodontitis, periodontitis.

Hygienic treatment of removable dentures.

Otorhinolaryngology: complex treatment of acute and chronic otitis media, sinusitis, tonsillitis, laryngitis, pharyngitis.

In children aged 3 to 14 years, it is used for the complex treatment of acute pharyngitis and / or exacerbation of chronic tonsillitis.

INN / Active ingredient

Benzyldimethyl 3- (myristoylamino) propyl ammonium chloride monohydrate

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

Contraindications

Hypersensitivity to the drug.

Specifications

Scope of the drug

General

Release form

Solution

Manufacturer country

Russia

Package quantity, pcs

one

Way of introduction

Locally

Vacation conditions

Without recipe

Volume, ml.

150 ml

Brand name

Infamed

Components

spray nozzle

The amount of the dosage form in the primary package

150 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Antiseptic

Anatomical and therapeutic characteristics

D08AJ Quaternary ammonium compounds

Dosage form

Topical solution

The target audience

Children

Expiration date in days

1095

Package weight, g

190

Category

:

Antiseptics and disinfectants

,

Antiviral

,

Regenerating agents

Mode of application

: https://translate.google.com/translate?hl=&sl=ru&tl=en&u=https://zz.buy-pharm.com/xzzatvb.html;Description

With prophylactic and therapeutic use, the drug has an immunomodulatory and antiviral effect. Efficacy against influenza viruses, herpes viruses (chickenpox, infectious mononucleosis), rotavirus has been experimentally and clinically established. The drug reduces the concentration of the virus in the affected tissues, affects the system of endogenous interferons and associated cytokines, induces the formation of endogenous "early" interferons (IFN a /?) And gamma-interferon (IFN?). Stimulates the humoral and cellular immune response. Increases the production of antibodies (including secretory IgA), activates the functions of T-effectors, T-helpers (Tx), and normalizes their ratio. Increases the functional reserve of Th and other cells involved in the immune response. It is an inducer of a mixed Txl and Tx2-type immune response:increases the production of cytokines Txl (IFN?, IL-2) and Тх2 (IL-4, 10), normalizes (modulates) the balance of Тх1 / Тх2 activities. Increases the functional activity of phagocytes and natural killer cells (EK cells).

Name ENG

ANAFERON KID

Clinical and pharmacological group

Antiviral drug.

Immunomodulator

ATX code

Immunostimulants, Other antiviral drugs

Dosage

3mg

Structure

Affinity purified antibodies to human gamma interferon - 0.003 g *.

Excipients: lactose, microcrystalline cellulose, magnesium stearate.

* introduced in the form of a water-alcohol mixture of the active form of the active substance ***.

** The active form of the active substance is the active form with a content of not more than 10-16 ng / g of the active substance.

Indications

Prevention and treatment of acute respiratory viral infections (including influenza).

Complex therapy of infections caused by herpes viruses (infectious mononucleosis, chickenpox, labial herpes, genital herpes).

Complex therapy and prevention of recurrence of chronic herpesvirus infection, including labial and genital herpes.

Complex therapy and prevention of other acute and chronic viral infections caused by tick-borne encephalitis virus, enterovirus, rotavirus, coronavirus, calicivirus.

Application in the complex therapy of bacterial infections.

Complex therapy of secondary immunodeficiency states of various etiologies, including prevention and treatment of complications of viral and bacterial infections.

Contraindications

Increased individual sensitivity to the components of the drug. Children under 1 month old - for the prevention and treatment of influenza and ARVI in children. Children under 1 year old - for the treatment of infections caused by herpes viruses in children. Children up to 6 months old - for the treatment of acute intestinal infection caused by rotavirus. Lactase deficiency, lactose intolerance, glucose-galactose malabsorption.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

INN / Active ingredient

affinity purified antibodies to human interferon gamma

Specifications

Category

Homeopathy

Scope of the drug

General

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

twenty

Minimum age from

1 month

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Materia Medica Holding

The amount of the dosage form in the primary package

20 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Immunostimulating agent

Anatomical and therapeutic characteristics

L03 Immunostimulants

Dosage form

Lozenges

Expiration date in days

1095

The target audience

Children

Package weight, g

twenty

Mode of application

:

Inside. At a time - 1 tablet (keep in the mouth until completely dissolved - not during meals). Children from 1 month. When prescribing the drug to young children (from 1 month to 3 years), it is recommended to dissolve the tablet in a small amount (1 tablespoon) of boiled water at room temperature. SARS, influenza, intestinal infections, herpesvirus infections, neuroinfections. Treatment should be started as early as possible - when the first signs of an acute viral infection appear according to the following scheme: in the first 2 hours, the drug is taken every 30 minutes, then during the first day three more doses are taken at regular intervals. From the second day onwards, take 1 tablet 3 times a day until complete recovery. In the absence of improvement,on the third day of treatment with the drug for acute respiratory viral infections and influenza, you should consult a doctor. In the epidemic season, for prophylactic purposes, the drug is taken daily 1 time per day for 1-3 months. Genital herpes. In case of acute manifestations of genital herpes, the drug is taken at regular intervals according to the following scheme: 1-3 days - 1 tablet 8 times a day, then 1 tablet 4 times a day for at least 3 weeks. For the prevention of recurrence of chronic herpesvirus infection - 1 tablet per day. The recommended duration of the prophylactic course is determined individually and can be up to 6 months. When using the drug for the treatment and prevention of immunodeficiency states, in the complex therapy of bacterial infections - take 1 tablet per day.If necessary, the drug can be combined with other antiviral and symptomatic agents.

Dosage (volume) of the substance in the preparation

:

1 tab.

- antibodies to human gamma interferon affinity purified 0.003 g

Information on technical characteristics, delivery set, country of manufacture "